ℹ️
🇬🇧
Search
Search for publications relevant for "Plaque psoriasis"
Plaque psoriasis
Publication
Class
Person
Publication
Programmes
Export current view
publication
Is chronic plaque psoriasis triggered by microbiota in the skin?
2013 |
Faculty of Medicine in Pilsen
publication
Inhibition of interleukins 12 and 23 - experience of plaque psoriasis therapy by ustekinumab
2013 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
New knowledce about etanercept biological therapy of plaque psoriasis
2009 |
Faculty of Medicine in Hradec Králové
publication
New knowledce about etanercept biological therapy of plaque psoriasis
2009 |
First Faculty of Medicine
publication
Conventional treatment of chronic plaque psoriasis in the era of biological drug
2013 |
Publication without faculty affiliation
publication
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
2015 |
Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Third Faculty of Medicine
publication
Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study
2020 |
Faculty of Medicine in Pilsen
publication
Elevated levels of circulating biomarkers of cell death (nucleosomes) in the patients with plaque psoriasis treated with the Goeckerman regimen
2014 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Inhibition of interleukins 12 and 23- novel therapy for plaque psoriasis
2010 |
Faculty of Medicine in Hradec Králové
publication
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic
2024 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
publication
Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal
2019 |
Faculty of Medicine in Pilsen
publication
Individualized pharmacotherapy of plaque psoriasis with oral methotrexate: fiction or real possibility?
2012 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (Clinical trial IMMerge)
2020 |
Faculty of Medicine in Pilsen
publication
Czech Recommendations for Biological Therapy of Severe Plaque Psoriasis
2012 |
Faculty of Medicine in Pilsen, First Faculty of Medicine
publication
Czech Recommendations for Biological Therapy of Severe Plaque Psoriasis
2012 |
Publication without faculty affiliation
publication
The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
2008 |
First Faculty of Medicine
publication
Clinical evaluation of the effectiveness of Dr Michaels(R) (also branded as Soratinex(R)) products in the topical treatment of patients with plaque psoriasis
2016 |
Second Faculty of Medicine
publication
Dr Michaels(R) product family (also branded as Soratinex(R)) versus Methylprednisolone aceponate - a comparative study of the effectiveness for the treatment of plaque psoriasis
2016 |
Second Faculty of Medicine
publication
Biological therapy and plaque psoriasis: contemporary practice, future perspectives Stockholm, 16.-17.6.2011
2011 |
Faculty of Medicine in Hradec Králové
publication
Psoriasis vulgaris
2012 |
First Faculty of Medicine
publication
Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial
2014 |
Third Faculty of Medicine
publication
A European prospective, randomized placebo-controlled doubleblind Study on the efficacy and safety of Dr Michaels(R) (also branded as Soratinex(R)) product family for stable chronic plaque psoriasis
2016 |
Second Faculty of Medicine
publication
Selective access to the therapy of plaque psoriasis: a report on meeting in Vinna, 26.-27. Nov 2009
2010 |
Faculty of Medicine in Hradec Králové
publication
Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept
2014 |
Second Faculty of Medicine
publication
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial
2020 |
Faculty of Medicine in Pilsen
publication
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study
2021 |
Central Library of Charles University
publication
Znáhodněná dvojitě slepá studie léčby chronické ložiskové psoriázy (Yones, SS., Palmer, RA., Garibaldinos, TG., Hawk JLM.: Randomized Double-blind Trial of the Treatment of Chronic Plaque Psoriasis)
2007 |
First Faculty of Medicine
publication
Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CAIN457A2304
Publication without faculty affiliation